<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Generic Drug User Fee-Abbreviated New Drug Application, Prior Approval Supplement, and Drug Master File Fee Rates for Fiscal Year 2013</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Generic Drug User Fee-Abbreviated New Drug Application, Prior Approval Supplement, and Drug Master File Fee Rates for Fiscal Year 2013</h1>
    <p class="timestamp">Published: 2012-10-25 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the rate for the Abbreviated New Drug Application (ANDA), Prior Approval Supplement (PAS), and Drug Master File (DMF) fees related to the Generic Drug User Fee Program for fiscal year (FY) 2013. The Federal Food, Drug, and Cosmetic Act (the FD&C Act), as amended by the Generic Drug User Fee Amendments of 2012 (GDUFA), as further amended by the FDA User Fee Correction Act of 2012, authorizes FDA to assess and collect user fees for certain appli...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-26256</p>
    <p><strong>Publication Date:</strong> 2012-10-25</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/10/25/2012-26256/generic-drug-user-fee-abbreviated-new-drug-application-prior-approval-supplement-and-drug-master">https://www.federalregister.gov/documents/2012/10/25/2012-26256/generic-drug-user-fee-abbreviated-new-drug-application-prior-approval-supplement-and-drug-master</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-26256</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
